Related references
Note: Only part of the references are listed.Interaction of Platinum-based Drugs with Proteins: An Overview Representative Crystallographic Studies
Giarita Ferraro et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2021)
ESI MS studies highlight the selective interaction of Auranofin with protein free thiols
Carlotta Zoppi et al.
DALTON TRANSACTIONS (2020)
Protein interactions of dirhodium tetraacetate: a structural study
Giarita Ferraro et al.
DALTON TRANSACTIONS (2020)
Arsenoplatin-1 Is a Dual Pharmacophore Anticancer Agent
Denana Miodragovic et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2019)
Structural Characterization of a Gold/Serum Albumin Complex
Alessandro Pratesi et al.
INORGANIC CHEMISTRY (2019)
Beyond cisplatin: Combination therapy with arsenic trioxide
Denana Miodragovic et al.
INORGANICA CHIMICA ACTA (2019)
The leading established metal-based drugs: a revisitation of their relevant physico-chemical data
Damiano Cirri et al.
BIOMETALS (2019)
Photocytotoxic Pt(iv) complexes as prospective anticancer agents
Giovanni Canil et al.
DALTON TRANSACTIONS (2019)
A case of extensive protein platination: the reaction of lysozyme with a Pt(II)-terpyridine complex
Giarita Ferraro et al.
DALTON TRANSACTIONS (2018)
The NAMI A - human ferritin system: a biophysical characterization
Silvia Ciambellotti et al.
DALTON TRANSACTIONS (2018)
Reactions of Auranofin and Its Pseudohalide Derivatives with Serum Albumin Investigated through ESI-Q-TOF MS
Alessandro Pratesi et al.
INORGANIC CHEMISTRY (2018)
The combined activation of K(Ca)3.1 and inhibition of K(v)11.1/hERG1 currents contribute to overcome Cisplatin resistance in colorectal cancer cells
Serena Pillozzi et al.
BRITISH JOURNAL OF CANCER (2018)
Selection and characterization of a human ovarian cancer cell line resistant to auranofin
Ida Landini et al.
ONCOTARGET (2017)
Protein metalation by metal-based drugs: X-ray crystallography and mass spectrometry studies
L. Messori et al.
CHEMICAL COMMUNICATIONS (2017)
ESI-MS studies of the reactions of novel platinum(II) complexes containing O,O'-chelated acetylacetonate and sulfur ligands with selected model proteins
Tiziano Marzo et al.
BIOMETALS (2017)
Protein Metalation by Anticancer Metallodrugs: A Joint ESI MS and XRD Investigative Strategy
Antonello Merlino et al.
CHEMISTRY-A EUROPEAN JOURNAL (2017)
Cisplatin binding to proteins: A structural perspective
Luigi Messori et al.
COORDINATION CHEMISTRY REVIEWS (2016)
Cisplatin-Protein Interactions: Unexpected Drug Binding to N-Terminal Amine and Lysine Side Chains
Irene Russo Krauss et al.
INORGANIC CHEMISTRY (2016)
Effect of temperature on the interaction of cisplatin with the model protein hen egg white lysozyme
Giarita Ferraro et al.
JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY (2016)
Platinum(II) Complexes with O,S Bidentate Ligands: Biophysical Characterization, Antiproliferative Activity, and Crystallographic Evidence of Protein Binding
Carolin Muegge et al.
INORGANIC CHEMISTRY (2015)
Interactions between Anticancer trans-Platinum Compounds and Proteins: Crystal Structures and ESI-MS Spectra of Two Protein Adducts of trans-(Dimethylamino)(methylamino)dichloridoplatinum(II)
Luigi Messori et al.
INORGANIC CHEMISTRY (2014)
Chemical conversion of cisplatin and carboplatin with histidine in a model protein crystallized under sodium iodide conditions
Simon W. M. Tanley et al.
ACTA CRYSTALLOGRAPHICA SECTION F-STRUCTURAL BIOLOGY COMMUNICATIONS (2014)
Carboplatin binding to histidine
Simon W. M. Tanley et al.
ACTA CRYSTALLOGRAPHICA SECTION F-STRUCTURAL BIOLOGY COMMUNICATIONS (2014)
Structural dynamics of cisplatin binding to histidine in a protein
Simon W. M. Tanley et al.
STRUCTURAL DYNAMICS-US (2014)
Robust Structure and Reactivity of Aqueous Arsenous Acid-Platinum(II) Anticancer Complexes
Denana U. Miodragovic et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2013)
The chemistry of dinuclear analogues of the anticancer drug cisplatin. A DFT/CDM study
DV Deubel
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2006)
Share Paper
